15-55466995-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_130810.4(DNAAF4):āc.572A>Gā(p.Glu191Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.517 in 1,580,218 control chromosomes in the GnomAD database, including 215,443 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_130810.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF4 | NM_130810.4 | c.572A>G | p.Glu191Gly | missense_variant | 5/10 | ENST00000321149.7 | NP_570722.2 | |
DNAAF4-CCPG1 | NR_037923.1 | n.827A>G | non_coding_transcript_exon_variant | 4/16 | ||||
DNAAF4 | NM_001033560.2 | c.572A>G | p.Glu191Gly | missense_variant | 5/9 | NP_001028732.1 | ||
DNAAF4 | NM_001033559.3 | c.572A>G | p.Glu191Gly | missense_variant | 5/9 | NP_001028731.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF4 | ENST00000321149.7 | c.572A>G | p.Glu191Gly | missense_variant | 5/10 | 1 | NM_130810.4 | ENSP00000323275 | P1 |
Frequencies
GnomAD3 genomes AF: 0.484 AC: 73377AN: 151740Hom.: 18816 Cov.: 32
GnomAD3 exomes AF: 0.565 AC: 122158AN: 216136Hom.: 35582 AF XY: 0.558 AC XY: 65918AN XY: 118074
GnomAD4 exome AF: 0.520 AC: 743283AN: 1428360Hom.: 196612 Cov.: 36 AF XY: 0.520 AC XY: 369290AN XY: 709884
GnomAD4 genome AF: 0.483 AC: 73419AN: 151858Hom.: 18831 Cov.: 32 AF XY: 0.490 AC XY: 36380AN XY: 74236
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 28, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Primary ciliary dyskinesia 25 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at